Suchergebnisse - "Kow, Chia Siang"

PubPharm (7)

1

Can Renin-Angiotensin System Inhibitors Protect Against Acute Kidney Injury in Patients With COVID-19?

enthalten in: Critical care medicine | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Crit Care Med. 2022 Sep 1;50(9):1306-1317. - PMID 35607951

2

Effects of Angiotensin II Receptor Blockers on the Risk of Mortality in Patients with COVID-19 : An Updated Systematic Review and Meta-analysis of Randomized Trials

enthalten in: American journal of hypertension | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Am J Hypertens. 2022 May 10;35(5):462-469. - PMID 35512430

3

Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19

enthalten in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Int J Clin Pract. 2021 Jun;75(6):e14124. - PMID 33650197

4

Concordance of recommendations across clinical practice guidelines for the management of hypertension in Southeast Asia with internationally reputable sources

enthalten in: BMC cardiovascular disorders | 2021

von Kow, C. | Hasan, S. | Wong, P. | +1

5

Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

enthalten in: Expert review of cardiovascular therapy | 2021

von Kow, C. | Hasan, S.

CommentOn: Expert Rev Cardiovasc Ther. 2020 Apr;18(4):181-185. - PMID 32233710

6

Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients

enthalten in: Expert review of cardiovascular therapy | 2020

von Kow, C. | Thiruchelvam, K. | Hasan, S.

7

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2020

von Kow, C. | Zaidi, S. | Hasan, S.

1
[1]